4.6 Review

Diabetic dyslipidemia impairs coronary collateral formation: An update

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

The year in cardiovascular medicine 2021: dyslipidaemia

Lale Tokgozoglu et al.

Summary: The past year saw significant advancements in clinical lipidology, with a focus on exploring existing and novel therapeutic pathways for lowering LDL cholesterol and triglyceride-rich lipoproteins. Evidence on the role of Lp(a) in cardiovascular disease and the development of targeted therapeutics to reduce Lp(a) levels has brought renewed interest in this area. Once the cardiovascular outcome studies are completed, personalized lipid lowering therapy will be further enhanced.

COR ET VASA (2022)

Review Anatomy & Morphology

Factors causing variability in formation of coronary collaterals during coronary artery disease

S. Balakrishnan et al.

Summary: Coronary artery disease is a major cause of death worldwide, and restoring blood perfusion is the only remedy, although it may cause reperfusion injury and complications. Coronary collaterals act as natural bypasses, providing blood flow when the supplying artery is obstructed. Various independent variables, such as coronary artery morphology, lesion location, occlusion duration, coronary dominance, etc., affect collateral formation.

FOLIA MORPHOLOGICA (2022)

Article Biochemistry & Molecular Biology

Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients

Gen Ouchi et al.

Summary: The TG/LDL-C ratio is a reliable predictor of sd-LDL in type 2 diabetes patients, outperforming non-HDL-C.

LIPIDS IN HEALTH AND DISEASE (2022)

Review Cardiac & Cardiovascular Systems

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies

Xiao Jin et al.

Summary: This article summarizes the possible mechanisms of sdLDL-C in atherosclerosis (AS). Research has found that sdLDL-C increases the risk of AS by regulating gene networks, monocytes, and enzymes. Furthermore, the article reviews the effects of sdLDL-C on endothelial function, lipid metabolism, and inflammation, as well as discusses intervention methods.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

The year in cardiovascular medicine 2021: dyslipidaemia

Lale Tokgozoglu et al.

Summary: The past year has been an exciting time for clinical lipidology, with new therapies targeting novel pathways discovered through genetic studies. There has been exploration of various drugs to lower LDL cholesterol through different mechanisms. New evidence has led to renewed interest in lowering triglyceride-rich lipoproteins with new treatments. Lp(a) has come into focus with evidence on causality and new therapeutics that lower Lp(a) levels significantly. Personalized lipid lowering therapy can be further enhanced with the results of cardiovascular outcome studies using these new agents.

EUROPEAN HEART JOURNAL (2022)

Review Pharmacology & Pharmacy

PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?

Ioannis Felekos et al.

Summary: This review discusses the current trends in the use of PCSK-9 inhibitors and their role in the management of diabetic dyslipidemia, particularly when statins cannot be tolerated or achieve hypolipidemic targets.

CURRENT PHARMACEUTICAL DESIGN (2021)

Article Cardiac & Cardiovascular Systems

High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA

Daniel O. Bittner et al.

Summary: This study found that higher levels of EPA are associated with lower PCAT attenuation on coronary CTA, indicating a potential different composition of pericoronary adipose tissue, potentially caused by a lower degree of coronary inflammation.

ATHEROSCLEROSIS (2021)

Article Cardiac & Cardiovascular Systems

Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus

Liyao Fu et al.

Summary: The study indicated that the atherogenic index of plasma (AIP) could serve as a strong biomarker for predicting cardiovascular event risk in patients with type 2 diabetes mellitus.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Cardiac & Cardiovascular Systems

The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population

Xiao-cong Liu et al.

Summary: The study found a non-linear relationship between TyG index and the risk of all-cause and cardiovascular disease mortality, with threshold values of 9.36 and 9.52. Above these threshold points, TyG index was significantly associated with an increased risk of mortality.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

Association between the triglyceride glucose index and coronary collateralization in coronary artery disease patients with chronic total occlusion lesions

Ang Gao et al.

Summary: The study demonstrated a strong association between the TyG index and impaired collateralization in CAD patients with CTO lesions. Higher TyG index values were significantly correlated with an increased risk of less developed collateralization even after adjusting for confounding factors. The risk assessment performance of the TyG index for impaired collateralization was found to be better than other single metabolic abnormality indicators.

LIPIDS IN HEALTH AND DISEASE (2021)

Article Cardiac & Cardiovascular Systems

Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study

Hiroaki Ikezaki et al.

Summary: This study showed that small dense LDL-C, direct LDL-C, and lipoprotein(a) are significantly associated with ASCVD risk, with small dense LDL being the most atherogenic lipoprotein parameter.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Cholesterol Efflux and Collateral Circulation in Chronic Total Coronary Occlusion: Effect-Circ Study

Seonhwa Lee et al.

Summary: The study suggests that higher cholesterol efflux capacity of HDL may be associated with good coronary collateral circulation, potentially contributing to cardioprotection.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Review Cardiac & Cardiovascular Systems

Mechanisms and Treatment of Dyslipidemia in Diabetes

Ehete Bahiru et al.

Summary: Type 2 diabetes is associated with a specific pattern of dyslipidemia, with characteristic features such as low HDL levels, elevated small dense LDL particles, and high triglyceride levels. LDL lowering with statins is the mainstay therapy for managing diabetic dyslipidemia, with potential future therapies targeting HDL and triglyceride levels.

CURRENT CARDIOLOGY REPORTS (2021)

Review Biochemistry & Molecular Biology

The Effects of SGLT2 Inhibitors on Lipid Metabolism

Zsolt Szekeres et al.

Summary: SGLT2 inhibitors are effective in lowering blood glucose levels, body weight and body fat, reducing cardiovascular morbidity, and protecting renal function in diabetic patients. They also have a notable impact on lipid metabolism, regulating lipid synthesis, storage, and substrate utilization.

METABOLITES (2021)

Article Cardiac & Cardiovascular Systems

Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON

Alberto J. Lorenzatti et al.

Summary: The study demonstrates that evolocumab effectively reduces atherogenic lipids and lipoproteins in patients with T2DM. In individuals with high triglycerides receiving background statin therapy, evolocumab significantly decreased cholesterol levels from various ApoB-containing lipoproteins, and the majority of treated individuals achieved lipid treatment goals recommended by the European Society of Cardiology/European Atherosclerosis Society.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study

Tong Liu et al.

Summary: Metabolic syndrome is associated with coronary collateralization in patients with chronic total occlusion, with body mass index posing a greater risk. Scoring systems should be further explored for potential use in this population.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Biotechnology & Applied Microbiology

Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus

Juan Huang et al.

Summary: This study investigated the association between serum sdLDL-C levels and coronary heart disease in type 2 diabetes mellitus patients. Results indicated an independent correlation between sdLDL-C and the presence and severity of CHD, with higher incidence of major cardiovascular events in the high sdLDL-C group.

DISEASE MARKERS (2021)

Review Pharmacology & Pharmacy

Targeting AMPK by Statins: A Potential Therapeutic Approach

Sajad Dehnavi et al.

Summary: Statins, a group of lipid-lowering drugs, have been shown to regulate multiple proteins associated with different cellular pathways, including the 5'-adenosine monophosphate-activated protein kinase (AMPK) pathway, which plays a significant role in maintaining metabolic homeostasis. Statins can affect the AMPK pathway in various physiological and pathological ways, resulting in therapeutic effects on cancer, cardiovascular diseases, neurodegenerative disorders, and other conditions.
Review Cardiac & Cardiovascular Systems

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

Jane J. Lee et al.

Summary: The study found that higher cholesterol efflux capacity (CEC) was associated with lower adverse cardiovascular outcomes, with each standard deviation increase in CEC reducing the risk of adverse cardiovascular events. These findings suggest that CEC may be an important protective factor that could potentially be targeted for improving clinical outcomes.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol

Chandni Bardolia et al.

Summary: This narrative review discusses the role of ezetimibe, PCSK9 inhibitors, BDA, and inclisiran in therapy, and describes their relative pharmacokinetic (PK) profiles, efficacy and safety as monotherapy and combination therapy, as well as the cardiovascular benefits when used for hypercholesterolemia.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice

Michelangelo Rottura et al.

Summary: The study evaluated the management of high cardiovascular risk in patients with diabetes by examining prescribing behavior in general practitioners. It found that while there was a high usage of lipid-lowering drugs in these patients, some did not reach treatment targets. There were also instances of non-compliance with guidelines in the prescription of glucose-lowering drugs, highlighting the need for improved patient management to lessen the burden of diabetes on the healthcare system.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis

Jing Wu et al.

Summary: The study suggests that a higher AIP value may be independently associated with CAD in the adult population, regardless of symptomatic status or gender.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Statins and Peripheral Arterial Disease: A Narrative Review

Sergio Jansen-Chaparro et al.

Summary: PAD is a common atherosclerotic condition that can lead to decreased quality of life and increased risk of cardiac or cerebrovascular events. Statins are recommended for reducing cardiovascular events and mortality in PAD patients, but the prescribing rate is lower than in patients with coronary heart disease.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Circulating Chromogranin B Is Associated With Left Ventricular Functional Recovery After Successful Recanalization of Chronic Total Occlusion

Ying Shen et al.

Summary: Increased circulating CgB levels are associated with impaired left ventricular functional recovery following successful recanalization of chronic total occlusion in patients with stable coronary artery disease.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Triglyceride Glucose Index Is Associated With Arterial Stiffness and 10-Year Cardiovascular Disease Risk in a Chinese Population

Wen Guo et al.

Summary: The TyG index is independently associated with arterial stiffness and 10-year cardiovascular disease risk, even after adjusting for traditional risk factors.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

HDL in the 21st Century A Multifunctional Roadmap for Future HDL Research

Anand Rohatgi et al.

Summary: Low high-density lipoprotein cholesterol (HDL-C) is associated with adverse lifestyle choices, cardiovascular diseases, inflammatory disorders, and other conditions. Therapeutic strategies targeting HDL-C levels have not been successful, and future focus should be on optimizing HDL function for better outcomes.

CIRCULATION (2021)

Editorial Material Cardiac & Cardiovascular Systems

Omega-3 for Cardiovascular Diseases Where Do We Stand After REDUCE-IT and STRENGTH?

Angela Pirillo et al.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease

Brian H. Annex et al.

Summary: PAD is a significant global cause of disability and mortality, primarily due to atherosclerotic obstructions in the large arteries to the leg(s). Despite advances in surgical and endovascular procedures, treatment outcomes may be suboptimal at times due to comorbid conditions or severe microvascular disease.

CIRCULATION RESEARCH (2021)

Review Biochemistry & Molecular Biology

Lipid effects of glucagon-like peptide 1 receptor analogs

Amanda J. Berberich et al.

Summary: GLP-1 receptor agonists are increasingly used in diabetes management and obesity treatment, with studies showing potential cardiovascular benefits and modest lipid-lowering effects. These medications also demonstrate favorable effects on lipoprotein metabolism and may reduce the atherogenic potential of oxidized LDL.

CURRENT OPINION IN LIPIDOLOGY (2021)

Article Cardiac & Cardiovascular Systems

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

Takahito Doi et al.

Summary: This study compared the effects of active and comparator oils on lipid traits and C-reactive protein in the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT) and Long-Term Outcomes Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridaemia (STRENGTH). The results suggest that the difference in the risk reduction between REDUCE-IT and STRENGTH may be partly explained by the difference in the effects of comparator oils (mineral vs. corn) on lipid traits and C-reactive protein, rather than the active oils.

EUROPEAN HEART JOURNAL (2021)

Article Obstetrics & Gynecology

Exposure to cigarette smoke affects endometrial maturation including angiogenesis and decidualization

Naoko Kida et al.

Summary: Exposure to cigarette smoke affects endometrial maturation by reducing proliferation and increasing cell death in stromal cells, as well as influencing angiogenesis and decidualization processes in the reproductive system.

REPRODUCTIVE MEDICINE AND BIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

Takahito Doi et al.

Summary: This study analyzed data from two randomized trials and found that the differing results in the effect of high-dose, purified omega-3 fatty acids on the prevention of ASCVD in REDUCE-IT and STRENGTH trials may be partly explained by differences in the effect of comparator oils, but not active oils, on lipid traits and C-reactive protein. The unexplained additional 13% risk reduction in REDUCE-IT may be due to other effects of EPA or mineral oil.

EUROPEAN HEART JOURNAL (2021)

Review Endocrinology & Metabolism

Dyslipidemia Management in Adults With Diabetes

Julieta Lazarte et al.

CANADIAN JOURNAL OF DIABETES (2020)

Review Peripheral Vascular Disease

Role of VEGFs in metabolic disorders

M. di Somma et al.

ANGIOGENESIS (2020)

Review Endocrinology & Metabolism

Causes and Consequences of Hypertriglyceridemia

Chris J. Packard et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Cardiac & Cardiovascular Systems

High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta -analysis

Maria T. Soria-Florido et al.

ATHEROSCLEROSIS (2020)

Editorial Material Cell Biology

Arteriogenesis and Therapeutic Angiogenesis in Its Multiple Aspects

Elisabeth Deindl et al.

Article Peripheral Vascular Disease

Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression

Hiroaki Ikezaki et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2020)

Review Cardiac & Cardiovascular Systems

Exercise Training as a Mediator for Enhancing Coronary Collateral Circulation: A Review of the Evidence

Thomas Nickolay et al.

CURRENT CARDIOLOGY REVIEWS (2020)

Review Cardiac & Cardiovascular Systems

Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease

Alan Chait et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Article Pharmacology & Pharmacy

Evolocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, promotes angiogenesis in vitro

Leila Safaeian et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis

Satoshi Ida et al.

CARDIOVASCULAR DIABETOLOGY (2019)

Review Biochemistry & Molecular Biology

The Human Coronary Collateral Circulation, Its Extracardiac Anastomoses and Their Therapeutic Promotion

Bigler Marius Reto et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Cardiac & Cardiovascular Systems

An update on pharmacotherapies in diabetic dyslipidemia

Manasvi Gupta et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2019)

Review Cardiac & Cardiovascular Systems

Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease

Ying Shen et al.

CARDIOVASCULAR DIABETOLOGY (2019)

Article Medicine, General & Internal

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Cardiac & Cardiovascular Systems

Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion

Ying Shen et al.

CARDIOVASCULAR DIABETOLOGY (2018)

Review Pharmacology & Pharmacy

High-density Lipoprotein (HDL) Dysfunction and the Future of HDL

Sibel Ertek

CURRENT VASCULAR PHARMACOLOGY (2018)

Review Cardiac & Cardiovascular Systems

An Exercise in Cardiac Metabolism

Stephen C. Kolwicz

FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes

Yang Dai et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Biology

Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease

Y. Fan et al.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)

Article Cardiac & Cardiovascular Systems

C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis

Lin Lu et al.

EUROPEAN HEART JOURNAL (2016)

Article Cardiac & Cardiovascular Systems

Coronary collateral development and arterial stiffness in patients with chronic coronary total occlusions

Ahmet Oytun Baykan et al.

SCANDINAVIAN CARDIOVASCULAR JOURNAL (2015)

Review Cardiac & Cardiovascular Systems

The dynamics of the coronary collateral circulation

Marco Zimarino et al.

NATURE REVIEWS CARDIOLOGY (2014)

Article Hematology

NR4A Orphan Nuclear Receptors Transcriptional Regulators of Gene Expression in Metabolism and Vascular Biology

Yue Zhao et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)

Article Hematology

Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice

Vincent van Weel et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Effect of statin treatment on coronary collateral development in patients with diabetes mellitus

I Dincer et al.

AMERICAN JOURNAL OF CARDIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Serum level of lipoprotein (a) is inversely associated with the development of coronary collateral circulation

A Dursun et al.

CORONARY ARTERY DISEASE (2006)

Article Cardiac & Cardiovascular Systems

Delayed arteriogenesis in hypercholesterolemic mice

D Tirziu et al.

CIRCULATION (2005)